Table 2 Participant characteristics at baseline and at 4 and 8 weeks after study commencement

Menopausal symptom score

  MSS score

9.9 (5.2)

8.5 (5.0)**

8.3 (5.0)***

<0.0001^a

  HADS-anxiety subscale score

5.3 (2.7)

4.8 (2.4)^#

4.9 (2.9)^#

0.04^b

  HADS-depression subscale score

4.7 (3.2)

4.6 (3.4)

4.4 (3.3)

0.32^b

  Athens Insomnia Scale score

3.7 (2.3)

3.4 (2.4)

3.8 (2.8)

0.16^b

Body composition

  Height, cm

157.5 (4.9)

157.5 (4.9)

157.5 (4.9)

0.50^b

  Weight, kg

55.0 (8.5)

54.9 (8.6)

55.0 (8.6)

0.13^a

  Body mass index, kg/m²

22.2 (3.2)

22.1 (3.2)

22.2 (3.2)

0.34^a

  Fat mass, kg

15.7 (6.1)

15.8 (6.2)

15.7 (6.2)

0.58^b

  Muscle mass, kg

37.0 (3.1)

36.9 (3.0)

37.1 (3.0)

0.046^a

Blood pressure and heart rate

  Systolic blood pressure, mmHg

116.9 (14.1)

117.8 (14.3)

117.0 (13.8)

0.87^b

  Diastolic blood pressure, mmHg

75.4 (10.4)

75.2 (9.7)

74.5 (9.3)

0.23^b

  Heart rate, min⁻¹

62.6 (9.4)

64.4 (8.6)^##

63.8 (8.2)^##

0.03^b

Resting Energy Expenditure

1980 (368)

2108 (440)**

2149 (470)**

0.003^a

Blood examination

  Triglycerides, mg/dL

115.9 (84.0)

116.3 (70.2)

107.4 (75.3)

0.25^b

  Total cholesterol, mg/dL

213.1 (33.4)

213.9 (36.1)

212.2 (36.8)

0.76^a

  LDL cholesterol, mg/dL

120.3 (28.8)

121.1 (31.2)

120.2 (32.2)

0.87^a

  HDL cholesterol, mg/dL

73.2 (16.3)

75.3 (14.9)

74.6 (15.0)

0.31^a

  Glucose, mg/dL

98.9 (16.6)

98.8 (11.6)

99.2 (19.0)

0.51^b

  HbA1c, %

5.3 (0.4)

5.3 (0.4)

5.4 (0.4)

0.36^b